HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Z B Liu Selected Research

daratumumab

8/2023[Safety and feasibility of 120 min rapid infusion regimen of daratumumab in patients with multiple myeloma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Z B Liu Research Topics

Disease

2Sensorineural Hearing Loss
06/2023 - 06/2019
2Tinnitus
06/2023 - 06/2019
2Neoplasms (Cancer)
01/2018 - 09/2016
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2017 - 09/2016
1Multiple Myeloma
08/2023
1Vertigo (Positional Vertigo)
06/2019
1Invasive Candidiasis
10/2017

Drug/Important Bio-Agent (IBA)

2Isotretinoin (Accutane)FDA LinkGeneric
01/2017 - 09/2016
1daratumumabIBA
08/2023
1SteroidsIBA
06/2023
1GlucocorticoidsIBA
06/2019
1MethylprednisoloneFDA LinkGeneric
06/2019
1Histone Deacetylase 6IBA
01/2018
1Fluconazole (Zonal)FDA LinkGeneric
10/2017
1EchinocandinsIBA
10/2017
1Cyclin D1IBA
09/2016
1Rituximab (Mabthera)FDA Link
09/2016
1Caspase 9IBA
09/2016
1SolventsIBA
09/2016
1Coloring Agents (Dyes)IBA
09/2016
1InterferonsIBA
09/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2016
1Bortezomib (Velcade)FDA Link
09/2016

Therapy/Procedure

1Aftercare (After-Treatment)
06/2023
1Therapeutics
10/2017